跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MENDICOF SYRUP (REVISED FORMULA)
Approved
THERAPEUTIC
MENDICOF SYRUP (REVISED FORMULA)
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 15, 2001
Approval ID
706dfff6ad3a734d
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
706dfff6ad3a734d
Drug Name
MENDICOF SYRUP (REVISED FORMULA)
Product Name
MENDICOF SYRUP (REVISED FORMULA)
Approval Number
SIN11516P
Approval Date
2001-05-15
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
DEXTROMETHORPHAN HBr
15 mg/5 ml
PSEUDOEPHEDRINE HCl
30 mg/5 ml
DEXCHLORPHENIRAMINE MALEATE
2 mg/5 ml
DEXCHLORPHENIRAMINE MALEATE
2 mg/5 ml
DEXTROMETHORPHAN HBr
15 mg/5 ml
PSEUDOEPHEDRINE HCl
30 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 15, 2001
Approval ID
706dfff6ad3a734d
Type
Therapeutic
Back to HSA Approvals
MENDICOF SYRUP (REVISED FORMULA) - HSA Drug Approval Details